Carl Zeiss Meditec AG (ETR:AFX – Get Free Report)’s stock price shot up 2.3% during trading on Friday . The company traded as high as €47.00 ($48.45) and last traded at €46.56 ($48.00). 224,325 shares changed hands during trading, an increase of 138% from the average session volume of 94,405 shares. The stock had previously closed at €45.52 ($46.93).
Carl Zeiss Meditec Stock Performance
The firm has a market capitalization of $4.12 billion, a PE ratio of 20.18, a price-to-earnings-growth ratio of 2.83 and a beta of 0.98. The company has a quick ratio of 2.47, a current ratio of 3.51 and a debt-to-equity ratio of 6.74. The firm has a 50-day moving average price of €54.62 and a 200 day moving average price of €60.46.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Stories
- Five stocks we like better than Carl Zeiss Meditec
- EV Stocks and How to Profit from Them
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- How to Most Effectively Use the MarketBeat Earnings Screener
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- Manufacturing Stocks Investing
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
